Generation Bio is a biotechnology company changing what is possible for people living with T cell-driven autoimmune diseases. The company is developing a new modality of therapeutics leveraging its T cell selective cell-targeted lipid nanoparticle (ctLNP) to deliver siRNA in vivo, enabling modulation of T cell activity that causes inflammation and auto-reactive tissue destruction.
Company Details
- Employees
- 121
- Founded
- -
- Address
- 301 Binney Street,
- in****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- generationbio.com
- Keywords
- Biotechnology, LNPs, siRNA, Autoimmune Disease, T cells.
- HQ
- Cambridge, Massachusetts
Generation Bio Questions
Generation Bio's website is generationbio.com
Generation Bio's LinkedIn profile is https://www.linkedin.com/company/generationbio
Generation Bio has
121 employees.
View email and phone details for 121
employees at Generation Bio.
Generation Bio's industry is
Biotechnology Research
Generation Bio's top competitors are
Alnylam Pharmaceuticals,
Tessera Therapeutics,
Verve Therapeutics,
Orna Therapeutics,
Vertex Pharmaceuticals,
Flagship Pioneering,
Beam Therapeutics,
Editas Medicine,
Generate:biomedicines,
Intellia Therapeutics, Inc..
Generation Bio's support email address is info@generationbio.com
Generation Bio's categories are Biotechnology Research
Generation Bio's founding year is 2016
